Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TRIP13 exerts a cancer‐promoting role in cervical cancer by enhancing Wnt/β‐catenin signaling via ACTN4
Xiaoying Liu, Xin Shen, Jing Zhang
Environmental Toxicology (2021) Vol. 36, Iss. 9, pp. 1829-1840
Closed Access | Times Cited: 18

Showing 18 citing articles:

RBM15 m6A modification‐mediated OTUB2 upregulation promotes cervical cancer progression via the AKT/mTOR signaling
Yan Song, Q. Wu
Environmental Toxicology (2023) Vol. 38, Iss. 9, pp. 2155-2164
Closed Access | Times Cited: 11
Targeting Thyroid Hormone Receptor Interacting Protein (TRIP13) for Cancer Therapy: A Promising Approach
Surya P. Singh, Krishnendu Goswami, Gopal Pathuri, et al.
DNA (2025) Vol. 5, Iss. 1, pp. 3-3
Open Access
Thyroid hormone receptor interacting protein 13 is associated with prognosis and immunotherapy efficacy in human cancers: a pan-cancer analysis
Suli Zheng, Hongyi Wang, Yingyi Wang
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
LASSO and Bioinformatics Analysis in the Identification of Key Genes for Prognostic Genes of Gynecologic Cancer
Shaohua Yu, Jia-Hua Cai, De-Lun Chen, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 11, pp. 1177-1177
Open Access | Times Cited: 24
KIF18B promotes breast cancer cell proliferation, migration and invasion by targeting TRIP13 and activating the Wnt/β‑catenin signaling pathway
Lan Liu, Zhaofeng Zhang, Xiulin Xia, et al.
Oncology Letters (2022) Vol. 23, Iss. 4
Open Access | Times Cited: 16
Targeting of oncogenic AAA-ATPase TRIP13 reduces progression of pancreatic ductal adenocarcinoma
Farrukh Afaq, Sumit Agarwal, Prachi Bajpai, et al.
Neoplasia (2023) Vol. 47, pp. 100951-100951
Open Access | Times Cited: 10
The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13–MAPK–YWHAE signaling pathway
Yingcong Wang, Sanfeng Dong, Ke Hu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 8
LncRNA CARMN inhibits cervical cancer cell growth via the miR-92a-3p/BTG2/Wnt/β-catenin axis
Lijun Wang, Hu Zhao, Ying Fang, et al.
Physiological Genomics (2022) Vol. 55, Iss. 1, pp. 1-15
Closed Access | Times Cited: 11
TRIP13 Activates Glycolysis to Promote Cell Stemness and Strengthen Doxorubicin Resistance of Colorectal Cancer Cells
Guangyi Liu, Huan Wang, Rui Ran, et al.
Current Medicinal Chemistry (2024) Vol. 31, Iss. 22, pp. 3397-3411
Closed Access | Times Cited: 2
UBP43 promotes epithelial ovarian carcinogenesis via activation of β‐catenin signaling pathway
Hongyang Xie, Junyu Chen, Changyan Ma, et al.
Cell Biology International (2023) Vol. 47, Iss. 8, pp. 1427-1440
Closed Access | Times Cited: 4
High expression of TRIP13 is associated with tumor progression in H. pylori infection induced gastric cancer
Longxiang Wu, Qiu Xue, Xiaochun Xia
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis (2024) Vol. 828, pp. 111854-111854
Closed Access | Times Cited: 1
TRIP13 Plays an Important Role in the Sensitivity of Leukemia Cell Response to Sulforaphane Therapy
Lei Liu, Baixue Liao, Ruiling Fan, et al.
ACS Omega (2024) Vol. 9, Iss. 24, pp. 26628-26640
Open Access | Times Cited: 1
TRIP13 − a potential drug target in cancer pharmacotherapy
Samuel J. Bunu, Haiyan Cai, Leyun Wu, et al.
Bioorganic Chemistry (2024) Vol. 151, pp. 107650-107650
Closed Access | Times Cited: 1
ACTN4 is associated with the malignant potential of thymic epithelial tumors through the β‐catenin/Slug pathway
Hideki Nagata, Soichiro Funaki, Kenji Kimura, et al.
Cancer Science (2024) Vol. 115, Iss. 11, pp. 3636-3647
Open Access | Times Cited: 1
Role of TRIP13 in human cancer development
Chaohu Chen, Li Pan, Guangrui Fan, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 1
OTX1 promotes tumorigenesis and progression of cervical cancer by regulating the Wnt signaling pathway
Limin Zhou, Hongying Li, Dunlan Zhang, et al.
Oncology Reports (2022) Vol. 48, Iss. 5
Open Access | Times Cited: 7
Gastric Cancer Biomarker Candidates Identified by Machine Learning and Integrative Bioinformatics: Toward Personalized Medicine
Vigneshwar Suriya Prakash Sinnarasan, Dahrii Paul, Rajesh Das, et al.
OMICS A Journal of Integrative Biology (2023) Vol. 27, Iss. 6, pp. 260-272
Closed Access | Times Cited: 2
Thyroid Hormone Receptor Interacting Protein 13 Is Associated with Prognosis and Immunotherapy Efficacy in Human Cancers: A Pan-cancer Analysis
Suli Zheng, Hongyi Wang, Yingyi Wang
Research Square (Research Square) (2024)
Open Access
TRIP13 as a prognostic marker and its correlation with clinicopathological features in human cancers: a meta-analysis
LI Ji-pin, Hongyang Deng, Qi Xiao, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top